产品名称 | Seraseq® FFPE HRD Low-Positive RM(SeraCare) |
---|---|
目录号 | 0710-2645 |
别名 | N/A |
外观 | N/A |
分子量 | N/A |
CAS | N/A |
溶解度 | N/A |
存储条件 | N/A |
保存时间 | N/A |
备注1 | N/A |
备注2 | N/A |
目录号 | 规格 | 价格 | 库存状态 | |
0710-2645 | 1 x 10 µm | 咨询客服 | 咨询客服 |
品名:Seraseq® FFPE HRD Low-Positive RM
货号:0710-2645
品牌:SeraCare
Product Specifications - FFPE HRD Low-Positive RM
GIS*:54 +2
Format:FFPE
Size:1 x 10um curl
DNA Yield*:>100 ng
Details
Genomic instability resulting from homologous recombination DNA repair deficiency (HRD) is a response biomarker
to assess ovarian and breast cancer patient eligibility for PARP inhibitor and platinum-based therapies. HRD
measurements have the potential to improve cancer therapy, however standardizing and democratizing HRD
measurements remains challenging. LGC SeraCare has developed HRD reference materials to support the
development, validation, and routine determination of HRD status in cancer patients.
•Derived from tumor and matched-normal human cell lines
•Blended to ~65% tumor content with SNP-matched normal cell lines
•Additional biosynthetic single-nucleotide variants (SNVs) of 4 homologous recombination repair (HRR) genes
•10 µm FFPE curl with DNA yield >100 ng per curl
•Full-process FFPE format reference material validated by NGS and microarray assays with various HRD algorithms
(see the Data Sheet for more details)
•Manufactured in GMP-compliant, ISO 13485-certified facilities
维百奥生物代理SeraCare对照及参比物质。
维百奥(北京)生物科技有限公司,自2018年与SeraCare(现隶属于LGC Clinical Diagnostics)合作以来,长期为中国客户
提供包括SeraSeq系列参比物质,领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质,可以用于任何
研发阶段,以确保临床基因组学检测结果的准确性。
SeraCare参比物质涵盖的范围:
1)Next Generation Sequencing
2)Sanger Sequencing
3)Real-time PCR and digital PCR (dPCR)
4)Microarray
主要特点
1)Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs,
and RNA fusions
2)Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs
3)Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA
in plasma, and FFPE
4)Manufactured in cGMP-compliant, ISO 13485-certified facilities
5)Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers